Etiology of severe invasive infections in young infants in rural settings in sub-Saharan Africa.
Journal
PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081
Informations de publication
Date de publication:
2022
2022
Historique:
received:
20
09
2021
accepted:
08
02
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
9
3
2022
Statut:
epublish
Résumé
Serious invasive infections in newborns are a major cause of death. Lack of data on etiological causes hampers progress towards reduction of mortality. This study aimed to identify pathogens responsible for such infections in young infants in sub-Saharan Africa and to describe their antibiotics resistance profile. Between September 2016 and April 2018 we implemented an observational study in two rural sites in Burkina Faso and Tanzania enrolling young infants aged 0-59 days old with serious invasive infection. Blood samples underwent blood culture and molecular biology. In total 634 infants with clinical diagnosis of serious invasive infection were enrolled and 4.2% of the infants had a positive blood culture. The most frequent pathogens identified by blood culture were Klebsiella pneumonia and Staphylococcus aureus, followed by Escherichia coli. Gram-negative isolates were only partially susceptible to first line WHO recommended treatment for neonatal sepsis at community level. A total of 18.6% of the infants were PCR positive for at least one pathogen and Escherichia coli and Staphylococcus aureus were the most common bacteria detected. Among infants enrolled, 60/634 (9.5%) died. Positive blood culture but not positive PCR was associated with risk of death. For most deaths, no pathogen was identified either by blood culture or molecular testing, and hence a causal agent remained unclear. Mortality was associated with low body temperature, tachycardia, respiratory symptoms, convulsions, history of difficult feeding, movement only when stimulated or reduced level of consciousness, diarrhea and/or vomiting. While Klebsiella pneumonia and Staphylococcus aureus, as well as Escherichia coli were pathogens most frequently identified in infants with clinical suspicion of serious invasive infections, most cases remain without definite diagnosis, making more accurate diagnostic tools urgently needed. Antibiotics resistance to first line antibiotics is an increasing challenge even in rural Africa.
Sections du résumé
BACKGROUND
Serious invasive infections in newborns are a major cause of death. Lack of data on etiological causes hampers progress towards reduction of mortality. This study aimed to identify pathogens responsible for such infections in young infants in sub-Saharan Africa and to describe their antibiotics resistance profile.
METHODS
Between September 2016 and April 2018 we implemented an observational study in two rural sites in Burkina Faso and Tanzania enrolling young infants aged 0-59 days old with serious invasive infection. Blood samples underwent blood culture and molecular biology.
RESULTS
In total 634 infants with clinical diagnosis of serious invasive infection were enrolled and 4.2% of the infants had a positive blood culture. The most frequent pathogens identified by blood culture were Klebsiella pneumonia and Staphylococcus aureus, followed by Escherichia coli. Gram-negative isolates were only partially susceptible to first line WHO recommended treatment for neonatal sepsis at community level. A total of 18.6% of the infants were PCR positive for at least one pathogen and Escherichia coli and Staphylococcus aureus were the most common bacteria detected. Among infants enrolled, 60/634 (9.5%) died. Positive blood culture but not positive PCR was associated with risk of death. For most deaths, no pathogen was identified either by blood culture or molecular testing, and hence a causal agent remained unclear. Mortality was associated with low body temperature, tachycardia, respiratory symptoms, convulsions, history of difficult feeding, movement only when stimulated or reduced level of consciousness, diarrhea and/or vomiting.
CONCLUSION
While Klebsiella pneumonia and Staphylococcus aureus, as well as Escherichia coli were pathogens most frequently identified in infants with clinical suspicion of serious invasive infections, most cases remain without definite diagnosis, making more accurate diagnostic tools urgently needed. Antibiotics resistance to first line antibiotics is an increasing challenge even in rural Africa.
Identifiants
pubmed: 35213629
doi: 10.1371/journal.pone.0264322
pii: PONE-D-21-30404
pmc: PMC8880396
doi:
Types de publication
Clinical Trial
Journal Article
Multicenter Study
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0264322Subventions
Organisme : Wellcome Trust
Pays : United Kingdom
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : NIAID NIH HHS
ID : K24 AI102972
Pays : United States
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
PLoS One. 2020 Jun 30;15(6):e0235391
pubmed: 32603368
Pediatr Res. 2013 Dec;74 Suppl 1:73-85
pubmed: 24366464
PLoS Med. 2021 Sep 30;18(9):e1003814
pubmed: 34591862
Lancet. 2008 Jan 12;371(9607):135-42
pubmed: 18191685
Lancet. 2017 Dec 17;388(10063):3027-3035
pubmed: 27839855
N Engl J Med. 2005 Jan 6;352(1):39-47
pubmed: 15635111
Lancet. 2018 Jul 14;392(10142):145-159
pubmed: 30025808
Lancet. 2014 Aug 2;384(9941):438-54
pubmed: 24853600
BMC Public Health. 2011 Apr 13;11 Suppl 3:S13
pubmed: 21501430
J Clin Microbiol. 2016 Jan;54(1):49-58
pubmed: 26491176
Emerg Infect Dis. 2018 Apr;24(4):710-717
pubmed: 29553312
Lancet Glob Health. 2018 Dec;6(12):e1297-e1308
pubmed: 30361107
Pediatr Infect Dis J. 2015 Jan;34(1):e1-8
pubmed: 25389919
PLoS One. 2016 Jun 23;11(6):e0158199
pubmed: 27336160
Lancet. 2019 Aug 31;394(10200):757-779
pubmed: 31257127
J Perinatol. 2016 May;36 Suppl 1:S1-S11
pubmed: 27109087
Clin Microbiol Infect. 2020 Feb;26(2):168-173
pubmed: 31654793
Lancet Infect Dis. 2019 Nov;19(11):1219-1234
pubmed: 31522858
PLoS One. 2021 Jan 14;16(1):e0244109
pubmed: 33444346
Lancet. 2014 Jul 12;384(9938):189-205
pubmed: 24853593
PLoS One. 2020 Aug 10;15(8):e0237085
pubmed: 32776958
Lancet Infect Dis. 2014 Aug;14(8):731-741
pubmed: 24974250
Clin Infect Dis. 2019 Jan 7;68(2):266-272
pubmed: 29868873